medigraphic.com
Órgano Ofical de la Facultad de Estomatología de la Benemérita Universidad Autónoma de Puebla

2016, Number 55

<< Back Next >>

Oral 2016; 17 (55)

Use of derivative matrix enamel (Emdogain®) combined with bovine hydroxyapatite (Nukbone®) and barrier collagen polyvinylpyrrolidone sponge (Fibroquel®) in periapical surgery: a clinic case report

Guerrero-Del Ángel F, Luna-Sánchez AD, Todd-Jiménez M, Tellez-Jiménez H, Ramírez LRA

Language: Spanish
References: 16
Page: 1412-1417
PDF size: 288.5 Kb.


ABSTRACT

Introduction. The periapical surgery is a minor oral surgery procedure that aims to strippage injuries or foreign bodies from the periapical region in anterior and posterior dental organs, in order to maintain functional one dental organ and associated endodontic treatment allows preserve functional in the oral cavity. Objective. Check the efficiency of biomaterials such as Emdogain (enamel matrix derived), Nukbone (bovine hydroxyapatite) and Fibroquel (polyvinyl pyrrolidone collagen sponge) in the healing and repair of the surgical area by clinical evaluation and radiographic check is made. Materials and methods. A female patient of 45 years old with the upper right first premolar with periapical radiolucent area previously treated with endodontic biomaterials selected and Emdogain (enamel matrix -derived), Nukbone (bovine hydroxyapatite) and Fibroquel (polyvinylpyrrolidone collagen sponge) were used in periapical bone defect. Results. Two weeks scarring soft tissue was observed without evidence of injury in the apical region, radiographically periapical repair region is evidenced by the presence of a radiopaque area at 12 weeks. Conclusion. The use of various biomaterials and the combination of these in the repair of periapical defects, allows dental organs functionally maintained in oral cavity with lower likelihood of recurrence of injury.


REFERENCES

  1. Vastardis S, et al. Evaluation of alogenic bone graft substitute for treatment of periodontal osseous defect: 6 Month Clinical results. Jan 2006.

  2. Sculean A. Healing of human intrabony defects following regenerative periodontal therapy with an enamel matrix protein derivated alone or combined with a bioactive glass a controlled. J Clin Periodontol 2005; 32: 111-17.

  3. Carinci F, et al. Effects of emdogain on osteoblast gene expression. Oral Diseases 2006; 12: 329-42.

  4. Bosshardt DD, et al. Effects of enamel matrix proteins on tissue formation along the roots of human teeth. J Periodontol Res 2005; 40: 158-67.

  5. Sculean A, et al. Nine–years results following treatment of intrabony periodontal defects with an enamel matrix derivative: report of 26 cases. J Periodontics Restorative Dent 2007; 27 (3): 221-29.

  6. Consensus Report. Position Paper: Periodontal Regeneration around natural teeth. Ann Periodontol 1996; 1: 667-70.

  7. Dori IF, et al. Clinical evaluation of an enamel matrix protein derivate combined with either natural bone mineral or b-tricalcium phosphate. Periodontol 2005; 76 (12): 2236-43.

  8. Gauthier O, et al. Macroporus biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone in growth. Biomaterials 1998; 19 (1-3): 133-39.

  9. Pousa X y col. Emdogain: Últimos avances en regeneración periodontal. Avances en Periodoncia. 2005. pp. 229-33.

  10. Hammarström L. Enamel matrix derivative, cementum development and regeneration. J Clin Periodontol 1997; 24: 658-68.

  11. Jepsen S, et al. Clinical outcomes after treatment of intrabony defects with an EMD/synthetic bone graft or EDM alone: a multicentre randomized-controlled clinical trial. J Clin Periodontol 2008; 35: 420-28.

  12. Sculean A, et al. Treatment of intrabony defects with enamel matrix proteins or bioabsorbable membranes. A 4-year follow-up split-mouth study. J Periodontol 2001; 72: 1695-701.

  13. Venezia E, et al. The use of enamel matrix derivative in the treatment of periodontal defects: A Literature Review and Meta- analysis. Crit Rev Oral Biol Med 2004; 15 (6): 382-402.

  14. Dennis R. Hunt , Dr. Sascha A. Jovanovic , Ulf M.E. Wikesjö, John M. Wozney Hyaluronan Supports Recombinant Human Bone Morphogenetic Protein-2 Induced Bone Reconstruction of Advanced Alveolar Ridge Defects in Dogs. A Pilot Study, Journal of Periodontology May 2001, 72(5): 651-58.

  15. Chimal-Monroy J, Bravo-Ruiz T, Krötzsch-Gómez Fernando, Diaz de León L. Implantes de FibroquelMR aceleran la formación de hueso nuevo en defectos óseos inducidos experimentalmente en cráneos de rata: un estudio histológico. Rev Biomed 1997; 8: 81-88.

  16. Izázkun G Penilla Acasuso, Ma. Guadalupe Marín González,- Edgar Krötzsch Gómez, Rosa María Salgado Curiel, Saúl Cano Colín. Efectos de la mezcla de colágena-PVP, sobre el metabolismo y proliferación celular de fibroblastos gingivales humanos cultivados. Revista Odontológica Mexicana 2008; 12(4): 184-91.




2020     |     www.medigraphic.com